ATXN2 and amyotrophic lateral sclerosis: Mutated ATXN2 with specific polyQ expansions enhances the Transactive Response DNA-binding Protein 43 kDa (TDP-43) aggregation, thereby promoting ALS pathogenesis [43,44].